Kite’s Huston joins Galapagos as CFO, COO
Plus: Burgess to head BD at Cerevel, and updates from Mablink, PathAI and Berlin
Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG) hired Thad Huston as CFO and COO, effective July 1. Huston will join the company from Kite Pharma Inc., part of Gilead Sciences Inc. (NASDAQ:GILD), where he is global head of finance and corporate operations. Huston joins the company as CEO Paul Stoffels works to shift its direction and focus; Stoffels discussed his vision for the company on The BioCentury Show in April.
Neuroscience disease company Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) hired Paul Burgess as chief business development and strategic operations officer, effective June 20. Burgess was COO and chief legal officer at Translate Bio Inc...